Bumper Offer - Urjas oil Just @ Rs. 1
Omnacortil 2.5 Tablet DT is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Allergy, Asthma, Skin Disorders. Other than this, Omnacortil 2.5 Tablet DT has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Omnacortil 2.5 Tablet DT depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The most common side effects of Omnacortil 2.5 Tablet DT are Skin scar, Mood swings, Unusual behavior. While these are the most often observed Omnacortil 2.5 Tablet DT side effects, there are can be others also. These have been listed below. These side effects of Omnacortil 2.5 Tablet DT are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Omnacortil 2.5 Tablet DT is Safe for pregnant women and Safe for women who are breastfeeding. It is important to know if Omnacortil 2.5 Tablet DT has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Omnacortil 2.5 Tablet DT related warnings section.
Individuals suffering from medical conditions like Infections, Tuberculosis (TB), Heart Disease must refrain from the use of Omnacortil 2.5 Tablet DT since this can cause severe adverse effects. The section on Omnacortil 2.5 Tablet DT contraindications lists all such conditions.
Additionally, Omnacortil 2.5 Tablet DT may also adversely react with other medicines. A complete list of these interactions is given below.
You should also be aware that Omnacortil 2.5 Tablet DT is safe while driving, and is addiction.
Omnacortil 2.5 Tablet DT is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Omnacortil 2.5 Tablet DT is used -
Severe
Moderate
Mild
Is the use of Omnacortil 2.5 Tablet DT safe for pregnant women?
There are no side effects of Omnacortil in pregnant women.
Is the use of Omnacortil 2.5 Tablet DT safe during breastfeeding?
Omnacortil does not show any harmful effects in lactating women.
What is the effect of Omnacortil 2.5 Tablet DT on the Kidneys?
Omnacortil can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Omnacortil 2.5 Tablet DT on the Liver?
There may be an adverse effect on the liver after taking Omnacortil. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Omnacortil 2.5 Tablet DT on the Heart?
Omnacortil can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Omnacortil 2.5 Tablet DT should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Omnacortil 2.5 Tablet DT unless your doctor advises you to do so -
Is this Omnacortil 2.5 Tablet DT habit forming or addictive?
Forming a habit of Omnacortil 2.5 Tablet DT has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Omnacortil 2.5 Tablet DT does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, but take Omnacortil 2.5 Tablet DT only as per medical advice.
Is it able to treat mental disorders?
No, Omnacortil 2.5 Tablet DT is not used to treat mental disorders.
Interaction between Food and Omnacortil 2.5 Tablet DT
Information is not available on the interaction of any foods with Omnacortil 2.5 Tablet DT, due to a lack of research on this.
Interaction between Alcohol and Omnacortil 2.5 Tablet DT
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Omnacortil 2.5 Tablet DT.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
